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We have isolated a new hematoside from guinea pig kidney. Like the usual hematoside (I13NeuAc- 
LacCer), isolated from human erythrocytes, this new hematoside contained glucose, galactose, and 
N-acetylneuraminic acid in an equimolar proportion. By thin-layer chromatography (TLC), however, it 
migrated faster than the usual hematoside. After mild alkaline hydrolysis the TLC mobility of this 
ganglioside became identical to that of the usual hematoside. The sialic acid in this ganglioside was 
susceptible to Clostridial neuraminidase. Based on TLC mobility and the results of periodate oxidation, 
the sialic acid of the new hematoside was identified as 9-0-acetyl-N-acetylneuraminic acid. Therefore, the 
structure of this new hematoside is 9-O-Ac-NeuAccu2+3Galfl1+4GLc,&l-+ 1’Cer. 
Ganglioside O-Acetylhematoside Sialic acid 
1. INTRODUCTION 
The possible involvement of gangliosides as tis- 
sue antigens, receptors, and in cell transformation 
has been reported [l-3]. Gangliosides, however, 
especially those found in extraneural tissues, have 
not been well characterized. Hematoside is one of 
the major gangliosides found mainly in extraneural 
tissues. Until now, 3 kinds of hematosides con- 
taining different types of sialic acids have been 
isolated [4]. They are the hematosides containing 
N-acetylneuraminic acid, N-glycolylneuraminic 
acid or 4-0-acetyl-N-glycolylneuraminic acid. 
Here, we describe the isolation and characteriza- 
tion of a new hematoside which is ~-O-AC- 
NeuAccu2-+3Gal~1+4GLc~l+l’Cer. 
2. MATERIALS AND METHODS 
2. I. Isolation of glycolipids 
One hundred guinea pig kidneys (purchased from 
Abbreviations: C-M-W, chloroform-methanol-water; 
TLC, thin-layer chromatography; GLC, gas-liquid chro- 
matography 
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Pel-Freeze Biologicals, Rogers, ARK) were chop- 
ped and homogenized in 5 vol. water using a Poly- 
tron grinder (Brinkman Instruments, Westbury 
NY) and subsequently lyophilized. The dried tissue 
was treated with 5OOml of acetone to obtain 42g 
dried powder. This powder was then homogenized 
with 10 vol. C-M (2: 1) and the mixture left over- 
night at room temperature. After filtering through 
a Buchner funnel, the residue was re-extracted 
twice with 500 ml of C-M (1: 1). The 2 extracts 
were combined and dried under vacuum. The total 
lipid extract was applied to a DEAE-Sephadex 
A-25 column (acetate form, 2.0 x 28 cm) as in [5]. 
The neutral lipids were eluted with 11 of C-M-W 
(30:60:8, by vol.) followed with 0.5 1 methanol. 
The monosialosylgangliosides were then eluted 
with 0.5 1 of methanol containing 0.01 M sodium 
acetate. The eluate was evaporated to dryness using 
a flash evaporator, dissolved in a small volume of 
C-M-W (30: 60: 8, by vol.) and dialyzed exhaus- 
tively against water for 24 h. The non-dialyzable 
materials were lyophilized to obtain 400mg crude 
gangliosides. This material was dissolved in chloro- 
form and applied to an Iatrobeads 6RS-8060 
(Iatron, Tokyo) column (1 x 90 cm) which had 
been equilibrated with chloroform. The column 
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was first washed with 200 ml chloroform, and the 
gangliosides were eluted with a linear gradient using 
450 ml C-M-W (83 : 16 : 0.1, by vol.) in the mixing 
chamber and 650 ml C-M-W (45 : 55 : 5, by vol.) 
in the reservoir [6]. Fractions of 8 ml each were col- 
lected. Fractions containing the new hematoside 
were pooled and further purified by repeating the 
Iatrobeads column chromatography. The yields of 
the new hematoside and the usual hematoside from 
100 kidneys were 1.1 mg and 10.0 mg, respectively. 
2.2. Preprution ofsiu~ic ucidfrom the new hema- 
toside 
The sialic acid of the new hematoside (5OOpg) 
was set free by Clostridial neuraminidase as in [7]. 
After incubation with the enzyme, the mixture was 
dialyzed against 2ml water for 2 days in a cold 
room with 2 changes of water. The combined di- 
alysates that contained free sialic acid were lyophi- 
lized, and further purified by ion-exchange column 
chromatography [8]. 
2.3. Method of analysis 
The purity of the new hematoside was examined 
by high performance TLC using the following 
solvent systems (by vol.): solvent I, C-M-W 
(60 : 32 : 7); solvent II, C-M-2.5 N ammonia 
(60:32:7); and solvent III, C-M-W (65:25:4). 
Resorcinol reagent 191 was used to detect ganglio- 
sides. The sugar composition of the new hemato- 
side was analyzed by GLC as trimethylsilyl ethers 
of 0-methylglycosides [IO]. GLC analyses were per- 
formed by using Hewlett-Packard Model 5830A 
gas chromatography unit equipped with a 3% SE 30 
column. Fatty acids were analyzed as their methyl 
esters by GLC using a 10070 DEGS column at 
190°C. The TLC of sialic acids was performed 
both on cellulose and silica gel plates (high-perfor- 
mance TLC plates). The cellulose plates were pre- 
washed with 0.1 N HCl before use [8]. The solvent 
system of ~-butanol-~-propranol-0.1 N HCI 
(1: 2 : 1, by vol.) was used for cellulose plates, and 
n-propanol-water (7 : 3, v/v), n-propanol-2.5 N 
ammonia (7 : 3, v/v) and C-M-W (5 : 5 : 1, by vol.) 
for the high-performance TLC plates. 
3. RESULTS AND DISCUSSION 
Fig.1 shows the elution profile of the first Iatro- 
beads column chromatography. The new hemato- 
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Fig. 1. Thin-layer chromatography showing the elution 
profile of monosialosylgangliosides from Iatrobeads col- 
umn. A 5081 aliquot of each fraction was analyzed by 
TLC with solvent I. 
side was eluted between phospholipids and the 
usual hematoxide N-acetylneuraminyllactosylcer- 
amide). The fractions containing the new hema- 
toside were pooled and purified again with Iatro- 
beads column chromatography. This procedure ef- 
fectively removed phospholipids from the new 
hematoside. Using solvents I and II, the new hema- 
toside migrated as a single band on TLC with a 
mobility faster than the usual hematoside, but 
slightly slower than 4-O-acetyl-N-glycolyllactosyl- 
ceramide obtained from horse erythrocytes 1111 
(fig.2). The TLC mobility of this ganglioside was 
found to be identical to that of N-acetylneura- 
minylgalactosylceramide (GM4). As in the case of 
4-0-acetyl-N-glycolylneuraminyllactosylceramide, 
this hematoside was easily converted into N-acetyl- 
neuraminyllactosylceramide by exposure to am- 
monia vapor as shown in fig.2. 
The carbohydrate composition of the new gang- 
lioside was found to contain an equimolar ratio of 
galactose, glucose and N-acetylneuraminic acid. 
This composition is identical to that of the usual 
hematoside. The new hematoside from guinea pig 
kidneys is different from 4-O-acetyl-iV-glycolyl- 
neuraminyllactosylceramide isolated from horse 
erythrocytes in their susceptibility to Clostridial 
neuraminidase. The hematoside from horse ery- 
throcytes was resistant to neuraminidase [ll], 
while the new hematoside was easily hydrolyzed by 
the same enzyme to produce lactosylceramide. The 
hematoside has two possible alkaline-labile sialic 
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Fig.2. Thin-layer chromatography showing the mobility 
of the new hematoside isolated from guinea pig kidney: 
(1) standard gangliosides, from top, N-acetylneura- 
minylgalactosylceramide and N-acetylneuraminyllacto- 
sylceramide; (2) the new hematoside; (3) the new hema- 
toside after exposure to ammonia vapor; (4) hematosides 
from horse erythrocytes, from top, 4-O-acetyl-N-gly- 
colylneuraminyllactosylceramide and two bands of N- 
glycolylneuraminyllactosylceramide; (5) horse hemato- 
sides after exposure to ammonia vapor; solvent II was 
used. 
acids: the sialic acid in lactone form and the sialic 
acid containing 0-acyl groups. Since the lactone 
form of sialic acid is known to be resistant to neur- 
aminidase [12], the alkaline-labile sialic acid in the 
new hematoside should be one of the O-acylated 
acids. The sialic acid released by neuraminidase 
was isolated and characterized by TLC as shown in 
fig.3. The sialic acid from the new hematoside 
moved at the same position as 9-O-acetyl-N-acetyl- 
neuraminic acid. The sialic acid released from the 
new hematoside was converted into N-acetylneura- 
minic acid by the treatment with ammonia. The 
same conclusion was also obtained from the ex- 
periment using a cellulose thin-layer plate with sol- 
vent I. 
Fig.3. Thin-layer chromatogram of sialic acid released 
from the new hematoside by neuraminidase: (1) N-gly- 
colylneuraminic acid; (2) N-acetyhreuraminic acid; (3) 
9-O-acetyl-N-acetylneuraminic acid; (4) the sialic acid 
from the new hematoside; solvent system, n-propanol- 
15 N ammonium hydroxide-water (7:0.5 :2.5, by vol.). 
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Fig.4. Thin-layer chromatogram of the new hematoside 
after mild periodate oxidation: (1) N-acetylneuraminyl- 
lactosylceramide; (2) 1 after periodate oxidation; (3) 
hematosides from horse erythrocytes; (4) 3 after perio- 
date oxidation; (5) the new hematoside; (6) 5 after 
periodate oxidation; solvent I was used. 
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Table 1 
Fatty acid composition of hematosides from guinea pig 
kidney a 
Fatty acid 
C16:O 
C16: 1 
C18:O 
C18:l 
c2o:o 
c21:o 
c22:o 
c22: 1 
c22:2 
C24:O 
C24: 1 
Hematoside New hematoside 
2.1 7.1 
tr. 0.4 
15.8 28.3 
5.3 10.3 
4.1 1.7 
4.9 1.1 
25.8 17.5 
4.1 tr. 
8.3 6.6 
14.4 10.7 
8.7 10.5 
a Each fatty acid is expressed as percentage of total fatty 
acids in each hematoside 
Fig.4 shows the effect of periodate oxidation on 
the new hematoside according to the condition in 
[ 131. Like 9-0-acetylneuraminic acid [ 131, the new 
hematoside was resistant to periodate oxidation. 
Under the same condition, more than 70% of 
N-acetylneuraminyllactosylceramide was oxidized. 
From these results, the position of the 0-acetyl 
group in the sialic acid of the new hematoside is 
concluded to be at C-9 of the sialic acid. 
The anomeric configuration and sugar sequence 
were determined by using exoglycosidases. The lac- 
tosylceramide which was produced after the treat- 
ment with Clostridial neuraminidase, was converted 
into glucosylceramide by jack bean,&galactosidase. 
From these results, the structure of the new hema- 
toside was assigned as 9-O-acetyl-N-acetylneura- 
minyllactosylceramide. 
The fatty acid composition of the new hemato- 
side is presented in table 1. Qualitatively, the new 
hematoside contained the same fatty acid composi- 
tion as that found in the usual hematoside. How- 
ever, the new hematoside contained twice as much 
of the shorter chain fatty acids such as C 16 : 0 and 
Cl8 : 1 than the usual hematoside. 
The existence of different molecular species of 
sialic acids has been reported [8]. The attachment 
of one or more acyl groups to the sialic acid in 
gangliosides may affect the biological properties of 
these gangliosides which have been shown to play 
many important biological roles. The exact bio- 
logical roles of 0-acetylated gangliosides, how- 
ever, remain to be elucidated. 
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